A phase 3 trial of AstraZeneca’s $800 million rare disease candidate has met its primary endpoint. The update keeps eneboparatide on track to come to market, but the lack of numbers in the readout ...
Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...
53mon MSN
Gene Hackman's home in Santa Fe was reportedly in a state before his tragic death last month, with a friend saying his wife ...
Collegium also announced today the appointments of three new executive leaders as the Company drives a new phase of growth: David Dieter, as Executive Vice President, General Counsel; Jane Gonnerman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results